济南降尿酸痛风食物(山东年轻人为什么会尿酸高怎么办) (今日更新中)

WASHINGTON, D.C. -- For weeks now, protests have touched every part of America, drawing people out of their homes and into the national debate over police reform and racial inequality.“Hands up – don’t shoot! Hands up – don’t shoot!” could be heard from protesters at a recent gathering in Ville Platte, Louisiana.Yet, while free speech is a part of the First Amendment, it doesn’t extend as far as you might think.One example: your job.“Those protections are nuanced,” said Mark Gaston Pearce, who is with Georgetown Law’s Workers Rights Institute and is a former chairman of the National Labor Relations Board under President Obama. “People are under the false impression that a private sector employment relationship affords you all of the rights that are guaranteed to you by the constitution – but it does not.”In other words, an employer, in a state where employment is “at will,” could potentially fire someone for attending or participating in a protest.“Provided, of course, that it’s non-discriminatory,” Pearce said.There are a few exceptions. Federal and state employees are protected because they work for the government. Unions also have some protections. Also, four states: New York, North Dakota, Colorado and California have specific laws protecting employees’ free speech rights.“But that’s four states in a 50-state country,” Pearce said.There are efforts underway in Congress that could expand free speech protections for employees under the “PRO Act.” It passed the House in February and is now in the Senate.“If labor law is reformed, then that would bring those kinds of protections to the public,” Pearce said.Until then, he added that an employee’s best defense may be found in their employer’s own words.“Oftentimes, a lot of that lies in the employee handbook and the publications they make you sign to prove that you read it – and most employees don’t read it,” Pearce said. “They need to know all of that stuff.”Because even in America, free speech doesn’t necessarily apply everywhere, all the time. 2037

WASHINGTON, D.C. – Two different doses of a thyroid medication are being recalled because they're not potent enough.The Food and Drug Administration announced Thursday that Acella Pharmaceuticals is voluntarily recalling one lot of 15-milligram and one lot of 120-milligram NP Thyroid?, Thyroid Tablets.The products may have as low as 87% of the labeled amount of levothyroxine, which is used to treat hypothyroidism (an underactive thyroid), according to the FDA.The company’s risk statement says patients being treated for hypothyroidism who receive sub potent NP Thyroid may experience symptoms of hypothyroidism, including fatigue, increased sensitivity to cold, constipation, dry skin, puffy face, hair loss, slow heart rate, depression, swelling of the thyroid gland and/or unexplained weight gain or difficulty losing weight.“There is reasonable risk of serious injury in newborn infants or pregnant women with hypothyroidism including early miscarriage, fetal hyperthyroidism, and/or impairments to fetal neural and skeletal development,” wrote Acella. “In elderly patients and patients with underlying cardiac disease toxic cardiac manifestations of hyperthyroidism may occur, such as cardiac pain, palpitations or cardiac arrhythmia.”So far, Acella says it has received four reports of "adverse events" for these lot numbers, possibly related to the recall.The products subject to recall are packed in 100-count bottles. Their lot numbers are M327E19-1 and M328F19-3. And their expiration dates are Oct. 2020 and November 2020.The products were distributed nationwide to Acella’s direct accounts, including wholesalers, pharmacies, and health care offices.“Acella is proactively notifying its wholesalers by email and phone to discontinue distribution of the two above referenced lots being recalled and is arranging for return of all recalled products,” wrote the company.Anyone who is currently taking NP Thyroid from the lots being recalled should not discontinue use without contacting their health care provider for further guidance and/or a replacement prescription, according to Acella.Anyone with questions about the recall can email Acella at recall@acellapharma.com or contact a representative at 1-888-280-2044.Click here for more information. 2272

WASHINGTON, D.C. – Firefighters recently pulled six dogs from a burning building in Washington D.C.Crews responded to the scene Tuesday after receiving a report of a row house on fire.Four residents made it out but told firefighters six dogs were still inside. One by one, the pups were pulled out of the building.One of the dogs was found unconscious but was treated and revived at the scene. DC Fire and EMS tweeted video of the dog being treated, along with a clip of the other rescued dogs. 502

We are so thankful for the brave members of @MNPDNashville and @NashvilleFD who responded today. These people saved lives. Please stay clear of the affected areas and allow first responders and investigators to continue their work. Stay safe, stay strong. https://t.co/kY4ENURSy0— Metro Nashville (@MetroNashville) December 25, 2020 346

WASHINGTON (AP) — The Trump administration says it will not work with an international cooperative effort to develop and distribute a COVID-19 vaccine because it does not want to be constrained by multilateral groups like the World Health Organization. The decision to go it alone, first reported by The Washington Post, follows the White House’s decision in early July to pull the United States out of the WHO. Trump claims the WHO needs reform and is heavily influenced by China. Some nations have worked directly to secure supplies of vaccine, but others are pooling efforts to ensure success against a disease that has no geographical boundaries. More than 150 countries are setting up the COVID-19 Vaccines Global Access Facility, or COVAX.White House spokesman Judd Deere says the U.S. will continue engaging with its global partners to defeat the virus, but will not be “constrained by multilateral organizations influenced by the corrupt World Health Organization and China.”The WHO says even governments making deals with individual vaccine makers would benefit from joining COVAX because it would provide backup vaccines in case the ones being made through bilateral deals with manufacturers aren’t successful. 1228

来源：资阳报